200 Berkeley Street,
Boston , MA, 02116
Boston , MA, 02116
Summary
The fund seeks to replicate the total return performance of the benchmark index, before fees and expenses, by investing in small-and mid-size companies in the United States.
The sub-adviser’s investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.
Next, the research team invests signi More
Webiste
Directors
Jul 3, 2023- Hassell H. McClellan
- James R. Boyle
- William H. Cunningham
- Grace K. Fey
- Marianne Harrison
- Deborah C. Jackson
- Gregory A. Russo
- Steven R. Pruchansky
- Andrew G. Arnott
- Frances G. Rathke
- Noni L. Ellison
- Dean C. Garfield
- Patricia Lizarraga
- Paul Lorentz
Chief Compliance Officer
- Trevor Swanberg
Price
- $ 45.42 ( +4.55 )
-
Oct 24, 2022Last Close
- Net Assets
-
$41.9M
Sep 28, 2022
- 52-Week High/Low
- $0 - $0
- Expense Ratio
- -
Performance
YTD
0%
3 Year
34.93%
5 Year
49.29%
Best
94.6%
2006
Worst
-38.65%
2008
Company Name |
Holding |
| Johnson and Johnson | 6.36 % |
| Unitedhealth Group Incorporated | 6.05 % |
| Pfizer Inc. | 4.04 % |
| Eli Lilly and Company | 3.33 % |
| Merck and Co. Inc. | 3.18 % |
| Thermo Fisher Scientific Inc. | 3.16 % |
| AbbVie Inc. | 3.01 % |
| Bristol-Myers Squibb Company | 2.71 % |
| Abbott Laboratories | 2.45 % |
| Danaher Corporation | 2.38 % |
| More | 2.38 % |
NAV
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| JHMH | 0% | 0% | 0% | -12% | 20.3% | 15.2% | 18.1% | 2.1% | 21.8% | -1.4% | |
| S&P 500 | -13.7% | 23.3% | 24.2% | -19.4% | 27.3% | 16.2% | 28.9% | -6.2% | 19.4% | 9.5% |
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| q1 | 0% | 0% | 0% | -4.3% | 2.9% | -12.6% | 8.5% | -0.9% | 8.9% | -5.3% | ||||
| q2 | 0% | 0% | 0% | -7.9% | 8.5% | 15.5% | -0.4% | 6.6% | 7.4% | 5.7% | ||||
| q3 | 0% | 0% | 0% | -4.5% | 0.7% | 4.2% | -4% | 12.8% | 1.1% | 2.9% | ||||
| q4 | 0% | 0% | 0% | 0% | 7.4% | 9.4% | 13% | -12.6% | 2.2% | -4.2% |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| 2024 | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |